• Protein and DNA analyses reveal that mutation in the immunoglobulin kappa light-chain constant region gene may cause hereditary amyloidosis.
Introduction
Immunoglobulin light-chain amyloidosis (AL) is the most frequent form of systemic amyloidosis. 1 It is a sporadic disease due to plasma cell dyscrasia with resulting amyloid fibril formation from monoclonal immunoglobulin light-chain either kappa or lambda. There are, however, a number of forms of systemic amyloidosis which are caused by mutations in other plasma proteins and are expressed with autosomal dominant genetics. 2 These inherited forms of amyloidosis may show predilection for specific organ involvement such as the heart, peripheral nervous system, or kidney, but are all systemic in nature and very often clinically mimic AL amyloidosis. A number of the inherited forms of systemic amyloidosis cause renal manifestations and, therefore, may be mistaken for AL amyloidosis which often presents with major renal dysfunction. 3 While plasma cell dyscrasia may be more prevalent in certain families, AL amyloidosis has rarely been reported in first degree relatives and no definite inheritance pattern has been identified. Here we report a systemic form of immunoglobulin light-chain amyloidosis which is inherited as an autosomal dominant trait and is associated with a mutation in the constant region of the kappa immunoglobulin light-chain.
The family
Six members (4 men and 2 women) of a family of eight died with renal failure between 53 and 74 years of age ( Figure 1 ). Five had received renal dialysis. Four (II-3, II-8, II-10, II-12) had the diagnosis of amyloidosis made by renal biopsy. Their mother (I-2) had died at age 58 with renal failure.
In the next generation, one man (III-2) with biopsy proven renal amyloidosis died at age 74 after several years treatment with renal dialysis, and two cousins (III-12 and III-15) have biopsy proven amyloidosis, one on renal biopsy (III-12) and one on gastric mucosal biopsy (III-
15, index case).
Review of medical histories revealed that one man (II-3) who died of renal failure also had amyloid deposition on laryngeal and lung biopsies verifying that he had a systemic form of amyloidosis. Medical records indicated that immunohistological analysis of kidney biopsies for four individuals showed positive staining for kappa light-chain, and laser dissected mass spectrometry analysis of amyloid identified on a gastric biopsy of a member of the third generation (III-15) identified kappa light-chain constant region peptides.
Amyloid protein characterization
Amyloid fibrils were isolated from formalin-fixed, paraffin-embedded renal tissue of one member of the family who died while on dialysis. 4 Tissue was solubilized in 8 M guanidine-HCl under reducing conditions, and solubilized protein subjected to amino acid sequencing on an Applied Biosystems Procise 491 cLC protein sequencer using the manufacturer's standard cycles and methods. Isolated protein was also subjected to tryptic digestion and resultant peptides separated by reverse phase HPLC and characterized by amino acid sequencing.
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Immunoglobulin light-chain isolation and characterization Serum (10 ml) from a member of the kindred with biopsy proven amyloidosis was made 33% saturated with ammonium sulfate at room temperature. Fractions containing Ig light-chains were combined, exhaustively dialyzed against distilled water and lyophilized. After tryptic digestion, peptides were separated by HPLC on a Beckman
Ultrasphere ODS column and isolated peptides subjected to amino acid sequencing on an Applied Biosystems Procise 491 cLC protein sequencer using the manufacturer's standard cycles and methods.
Histochemistry
Tissue biopsy sections (4 micron) were stained with haematoxylin and eosin. Sections were also stained with alkaline Congo red. Immunohistochemistry of biopsy tissues was performed by the indirect immunoperoxidase technique using rabbit anti-kappa and anti-lambda polyclonal 6 antisera and immunoperoxidase labeled goat anti-rabbit IgG antibody. Sections were developed with diaminobenzidine.
DNA analysis
DNA was isolated from EDTA-treated blood and formalin-fixed, paraffin-embedded tissue. 
Results
Review of medical records for several members of a family who died with renal failure documented that kidney biopsies demonstrated amyloid deposition in glomerular basement membrane and blood vessel walls. In several cases positive staining for kappa light-chain was described but evaluation for monoclonal gammopathy was negative (Table 1 ). In the present study amyloid deposition in a renal biopsy of subject III-12 was identified by routine histology, and electron microscopy demonstrated 7-10 micron fibrils consistent with amyloid ( Figure 2 ). Sequencing of DNA isolated from post mortem tissue of the subject whose amyloid fibril protein had been characterized also showed heterozygosity for the Ser131Cys change in the kappa light-chain gene. In addition, two children of subject II-7 who died with amyloidosis were positive for the Ser131Cys mutation indicating that their affected parent (II-7) had been an obligate carrier of the Ser131Cys mutation.
All forms of hereditary systemic amyloidosis identified so far are inherited in an autosomal dominant pattern which is consistent with the structural nature of mutant proteins that form amyloid fibrils. 2 Mutation in only one allele is sufficient for production of protein that can follow the amyloid fibril forming pathway.
In the usual type of Ig light-chain amyloidosis (AL) no hereditary pattern has been identified and the disease is considered "sporadic". The only definite requirement for amyloid formation appears to be a plasma cell dyscrasia that produces excess monoclonal amyloid fibril precursor protein. In addition, it has been proposed that certain amino acid residues in the variable region of the light-chain predispose to fibril formation with certain light-chain structures (e.g. lambda-6) having more fibril forming potential. 9, 10 While structure of the variable region dictates fibril formation, it is common to find some portions of the light-chain constant region, either kappa or lambda, in the final fibril product.
The immunoglobulin kappa light-chain amyloidosis described here is different. The disease is obviously hereditary and segregates with a Ser131Cys mutation in the constant region of the kappa light-chain gene. No significant amount of peptide sequence consistent with any known kappa variable region was identified in isolated fibrils. In one case subjected to mass spectrometry analysis, minor amounts of kappa variable peptide sequences were noted but included kappa-I, -II, and -III, and would not support presence of a monoclonal immunoglobulin ( Figure 6 ).
Essentially these are two different diseases, one the result of a monoclonal plasma cell dyscrasia in which the specific variable region of the light-chain is predisposed to amyloid fibril There are two reports of cases in which mutation in the kappa constant gene was associated with systemic amyloidosis. 12, 13 Both had a kappa light-chain mutation (Ser177Asn) identified in amyloid fibril isolates and both were from patients with plasma cell dyscrasias. In the case reported by Solomon, et al., 12 nucleotide sequencing of DNA from family members of the patient with light-chain amyloidosis was consistent with the Ser177Asn kappa constant region change being the result of a germ-line rather than a somatic mutation. A similar conclusion was proposed by the studies of Wally, et al., 13 with the suggestion that the Ser177Asn did not cause but contributed to the generation of amyloid formation. In both of the reported cases 12,13 rapid progression of clinical disease was noted. While it has been proposed that Ser177Asn is a kappa light-chain polymorphism as are Ala153Val and Val191Leu, additional studies are needed to support this hypothesis. Since there are no reports identifying the kappa
light-chain constant region Ser131Cys mutation in published studies, it is unlikely to meet the designation of a genetic polymorphism.
There have also been reports of AL amyloidosis in first degree relatives. Miliani, et al.,
reported three siblings with AL amyloidosis. 14 Gertz, et al., reported AL amyloidosis in three families. 15 Enquist, et al., reported a father and son with AL amyloidosis. 16 In all of these cases an underlying plasma cell dyscrasia was identified. Extensive searches for plasma cell dyscrasia in several of the patients in the present report of kappa light-chain amyloidosis were negative.
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